NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 155 filers reported holding NEKTAR THERAPEUTICS in Q1 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $316,000 | -78.9% | 6,562 | -53.4% | 0.00% | -66.7% |
| Q1 2018 | $1,496,000 | +78.7% | 14,077 | +0.4% | 0.00% | +200.0% |
| Q4 2017 | $837,000 | +381.0% | 14,016 | +90.9% | 0.00% | – |
| Q3 2017 | $174,000 | +22.5% | 7,341 | 0.0% | 0.00% | – |
| Q2 2017 | $142,000 | -58.5% | 7,341 | -50.0% | 0.00% | – |
| Q1 2017 | $342,000 | +280.0% | 14,682 | +100.0% | 0.00% | – |
| Q4 2016 | $90,000 | -28.6% | 7,341 | 0.0% | 0.00% | – |
| Q3 2016 | $126,000 | +21.2% | 7,341 | 0.0% | 0.00% | – |
| Q2 2016 | $104,000 | +4.0% | 7,341 | 0.0% | 0.00% | – |
| Q1 2016 | $100,000 | -19.4% | 7,341 | 0.0% | 0.00% | – |
| Q4 2015 | $124,000 | +55.0% | 7,341 | 0.0% | 0.00% | – |
| Q3 2015 | $80,000 | -12.1% | 7,341 | 0.0% | 0.00% | – |
| Q2 2015 | $91,000 | +12.3% | 7,341 | 0.0% | 0.00% | – |
| Q1 2015 | $81,000 | -28.9% | 7,341 | 0.0% | 0.00% | – |
| Q4 2014 | $114,000 | -100.0% | 7,341 | -70.4% | 0.00% | – |
| Q3 2014 | $299,047,000 | +217.8% | 24,776 | +237.5% | 0.00% | – |
| Q2 2014 | $94,112,000 | +5.8% | 7,341 | 0.0% | 0.00% | – |
| Q1 2014 | $88,973,000 | +6.8% | 7,341 | 0.0% | 0.00% | – |
| Q4 2013 | $83,320,000 | +8.7% | 7,341 | 0.0% | 0.00% | – |
| Q3 2013 | $76,677,000 | – | 7,341 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |